{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:02:40Z","timestamp":1790755360517,"version":"4.1.0"},"publisher-location":"New York, NY","reference-count":12,"publisher":"Springer US","isbn-type":[{"value":"9781071656068","type":"print"},{"value":"9781071656075","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2027]]},"DOI":"10.1007\/978-1-0716-5607-5_13","type":"book-chapter","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:45:30Z","timestamp":1790754330000},"page":"211-228","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunophenotyping of Cellular Therapy Products Against Oncogenic and Viral Targets"],"prefix":"10.1007","author":[{"given":"Christopher A.","family":"Lazarski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anushree A.","family":"Datar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Hanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep K.","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"13_CR1","doi-asserted-by":"publisher","first-page":"658314","DOI":"10.3389\/fimmu.2021.658314","volume":"12","author":"U Blache","year":"2021","unstructured":"Blache U, Weiss R, Boldt A, Kapinsky M, Blaudszun AR, Quaiser A, Pohl A, Miloud T, Burgaud M, Vucinic V, Platzbecker U, Sack U, Fricke S, Koehl U (2021) Advanced flow cytometry assays for immune monitoring of car-t cell applications. Front Immunol 12:658314. https:\/\/doi.org\/10.3389\/fimmu.2021.658314","journal-title":"Front Immunol"},{"key":"13_CR2","doi-asserted-by":"publisher","unstructured":"Dave H, Terpilowski M, Mai M, Toner K, Grant M, Stanojevic M, Lazarski C, Shibli A, Bien SA, Maglo P, Hoq F, Schore R, Glenn M, Hu B, Hanley PJ, Ambinder R, Bollard CM (2022) Tumor-associated antigen\u2013specific T cells with nivolumab are safe and persist in vivo in relapsed\/refractory Hodgkin lymphoma. Blood Adv 6(2):473\u2013485. https:\/\/doi.org\/10.1182\/bloodadvances.2021005343","DOI":"10.1182\/bloodadvances.2021005343"},{"issue":"26","key":"13_CR3","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1200\/JCO.19.00177","volume":"37","author":"AB Hont","year":"2019","unstructured":"Hont AB, Cruz CR, Ulrey R, O\u2019Brien B, Stanojevic M, Datar A, Albihani S, Saunders D, Hanajiri R, Panchapakesan K, Darko S, Banerjee P, Fortiz MF, Hoq F, Lang H, Wang Y, Hanley PJ, Dome JS, Bollard CM, Meany HJ (2019) Immunotherapy of relapsed and refractory solid tumors with ex vivo expanded multi-tumor associated antigen specific cytotoxic T lymphocytes: a phase I study. J Clin Oncol 37(26):2349\u20132359. https:\/\/doi.org\/10.1200\/JCO.19.00177","journal-title":"J Clin Oncol"},{"key":"13_CR4","doi-asserted-by":"publisher","unstructured":"Kinoshita H, Cooke KR, Grant M, Stanojevic M, Cruz CR, Keller M, Fortiz MF, Hoq F, Lang H, Barrett AJ, Liang H, Tanna J, Zhang N, Shibli A, Datar A, Fulton K, Kukadiya D, Zhang A, Williams KM, Dave H, Dome JS, Jacobsohn D, Hanley PJ, Jones RJ, Bollard CM (2022) Outcome of donor-derived TAA-T cell therapy in patients with high-risk or relapsed acute leukemia post allogeneic BMT. Blood Adv 6(8):2520\u20132534. https:\/\/doi.org\/10.1182\/bloodadvances.2021006831","DOI":"10.1182\/bloodadvances.2021006831"},{"key":"13_CR5","doi-asserted-by":"crossref","unstructured":"Keller MD, Bollard CM (2020) Virus-specific T-cell therapies for patients with primary immune deficiency. Blood 135(9):620\u2013628. https:\/\/doi.org\/10.1182\/blood.2019000924","DOI":"10.1182\/blood.2019000924"},{"key":"13_CR6","doi-asserted-by":"publisher","unstructured":"Bollard CM, Gottschalk S, Leen AM, Weiss H, Straathof KC, Carrum G, Khalil M, Wu MF, Huls MH, Chang CC, Gresik MV, Gee AP, Brenner MK, Rooney CM, Heslop HE (2007) Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer. Blood 110(8):2838\u20132845. https:\/\/doi.org\/10.1182\/blood-2007-05-091280","DOI":"10.1182\/blood-2007-05-091280"},{"key":"13_CR7","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/cyto.21735","volume":"94B","author":"JDM Campbell","year":"2018","unstructured":"Campbell JDM, Fraser AR (2018) Flow cytometric assays for identity, safety and potency of cellular therapies. CytometryB Clin Cytom 94B:725\u2013735. https:\/\/doi.org\/10.1002\/cyto.21735","journal-title":"CytometryB Clin Cytom"},{"key":"13_CR8","doi-asserted-by":"publisher","first-page":"830773","DOI":"10.3389\/fimmu.2022.830773","volume":"13","author":"A Peinelt","year":"2022","unstructured":"Peinelt A, Bremm M, Kreyenberg H, Cappel C, Banisharif-Dehkordi J, Erben S, Rettinger E, Jarisch A, Meisel R, Schlegel PG, Beck O, Bug G, Klusmann JH, Klingebiel T, Huenecke S, Bader P (2022) Monitoring of circulating CAR T cells: validation of a flow cytometric assay, cellular kinetics, and phenotype analysis following tisagenlecleucel. Front Immunol 13:830773. https:\/\/doi.org\/10.3389\/fimmu.2022.830773","journal-title":"Front Immunol"},{"issue":"7","key":"13_CR9","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.ymthe.2019.05.015","volume":"27","author":"SR Panch","year":"2019","unstructured":"Panch SR, Srivastava SK, Elavia N, McManus A, Liu S, Jin P, Highfill SL, Li X, Dagur P, Kochenderfer JN, Fry TJ, Mackall CL, Lee D, Shah NN, Stroncek DF (2019) Effect of cryopreservation on autologous chimeric antigen receptor T cell characteristics. Mol Ther 27(7):1275\u20131285. https:\/\/doi.org\/10.1016\/j.ymthe.2019.05.015","journal-title":"Mol Ther"},{"issue":"1","key":"13_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36126-7","volume":"14","author":"DKY Zhang","year":"2023","unstructured":"Zhang DKY, Adu-Berchie K, Iyer S, Liu Y, Cieri N, Brockman JM, Neuberg D, Wu CJ, Mooney DJ (2023) Enhancing CAR-T cell functionality in a patient-specific manner. Nat Commun 14(1):506. https:\/\/doi.org\/10.1038\/s41467-023-36126-7","journal-title":"Nat Commun"},{"issue":"4","key":"13_CR11","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00262-016-1803-z","volume":"65","author":"H Kared","year":"2016","unstructured":"Kared H, Martelli S, Ng TP, Pender SL, Larbi A (2016) CD57 in human natural killer cells and T-lymphocytes. Cancer Immunol Immunother 65(4):441\u2013452. https:\/\/doi.org\/10.1007\/s00262-016-1803-z","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"13_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27613-w","volume":"12","author":"I Otano","year":"2021","unstructured":"Otano I, Azpilikueta A, Glez-Vaz J, Alvarez M, Medina-Echeverz J, Cort\u00e9s-Dom\u00ednguez I, Ortiz-de-Solorzano C, Ellmark P, Fritzell S, Hernandez-Hoyos G, Nelson MH, Ochoa MC, Bola\u00f1os E, Cuculescu D, Ja\u00faregui P, Sanchez-Gregorio S, Etxeberria I, Rodriguez-Ruiz ME, Sanmamed MF, Teijeira \u00c1, Berraondo P, Melero I (2021) CD137 (4-1BB) costimulation of CD8+ T cells is more potent when provided in cis than in trans with respect to CD3-TCR stimulation. Nat Commun 12(1):7296. https:\/\/doi.org\/10.1038\/s41467-021-27613-w","journal-title":"Nat Commun"}],"container-title":["Methods in Molecular Biology","Immunophenotyping"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5607-5_13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:45:32Z","timestamp":1790754332000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5607-5_13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"ISBN":["9781071656068","9781071656075"],"references-count":12,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5607-5_13","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"assertion":[{"value":"1 October 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}